MedPath

Multi-center clinical trial for diagnostic value of sentinel node biopsy to detect lymph node metastasis in gastric cancer

Not Applicable
Conditions
Early gastric cancer
Registration Number
JPRN-UMIN000000476
Lead Sponsor
Japanese Society for sentinel node navigation surgery
Brief Summary

433 patients enrolled in the study, and 397 were deemed eligible on the basis of surgical findings. SN biopsy was performed in all the patients, and the SN detection rate was 97.5% (393 of 387). Sensitivity to predict lymph node metastasis was 93% (53 of 57), and accuracy of lymph node status based on SN concept was 99% (383 of 387). Only four negative-false cases were observed, and pathological analysis revealed that three of those biopsies were deeper than pT2 or tumors>4cm, and in one of pT1N0 case, SN metastasis was limited within the region of SN basins. We observed no serious adverse events related to endoscopic tracer injection and SN mapping procedure. (J Clin Oncol. 2013: 31:3704-10)

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Pregnancy Drug allergy Asthma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity to detect lymph node metastasis based on sentinel node biopsy
Secondary Outcome Measures
NameTimeMethod
Detection rate of sentinel nodes, The distribution and the number of sentinel nodes Incidence of adverse effect
© Copyright 2025. All Rights Reserved by MedPath